Advanced practice nurse management in multiple myeloma treated with oral therapy
Copyright © 2023 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved..
INTRODUCTION: Therapeutic approaches in Multiple Myeloma (MM) have considerably changed over the last few years, with effective oral chemotherapy and continuous treatment. In this context, the objective of this study was to examine the circuitry of an advanced practitioner nurse (APN)-led intervention that provided supportive care for MM patients treated with oral chemotherapy.
METHODS: This population-based study was conducted at the hematology department - Institut de Cancérologie Lucien Neuwirth (ICLN, Saint-Priest-en-Jarez), from April 2017 to September 2020. A follow-up program was established with a specialized APN in oncology.
RESULTS: All APN interventions were recorded, representing 1240 phone calls and 162 consultations for 42 MM patients. Eighty-two calls were referred to the physician with 45 consultations triggered. Most of the calls were frequent within the few first months, with a high request for information and reassurance, especially for treatment-naive or relapsed patients. In our study, the APN was able to manage multiple side effects through care organization (i.e., hospitalizations, transfusions) and a careful coordination between the primary care team and the hospital.
DISCUSSION: In order to respond to the high need for care pathway and safety improvement, especially in elderly population, we have initiated an original follow-up by an APN for MM patients treated with oral chemotherapy. While the role of APN has become prominent in the oncology field in recent years, its holistic approach has to be emphasized in further studies to bring a comprehensive perspective to health care coordination in the future.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:110 |
|---|---|
| Enthalten in: |
Bulletin du cancer - 110(2023), 12 vom: 01. Dez., Seite 1251-1259 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sapet, Manon [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Advanced practice nurse |
|---|
| Anmerkungen: |
Date Completed 01.12.2023 Date Revised 06.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.bulcan.2023.07.010 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361941471 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361941471 | ||
| 003 | DE-627 | ||
| 005 | 20240306232417.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.bulcan.2023.07.010 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1318.xml |
| 035 | |a (DE-627)NLM361941471 | ||
| 035 | |a (NLM)37696744 | ||
| 035 | |a (PII)S0007-4551(23)00346-6 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sapet, Manon |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Advanced practice nurse management in multiple myeloma treated with oral therapy |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.12.2023 | ||
| 500 | |a Date Revised 06.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a INTRODUCTION: Therapeutic approaches in Multiple Myeloma (MM) have considerably changed over the last few years, with effective oral chemotherapy and continuous treatment. In this context, the objective of this study was to examine the circuitry of an advanced practitioner nurse (APN)-led intervention that provided supportive care for MM patients treated with oral chemotherapy | ||
| 520 | |a METHODS: This population-based study was conducted at the hematology department - Institut de Cancérologie Lucien Neuwirth (ICLN, Saint-Priest-en-Jarez), from April 2017 to September 2020. A follow-up program was established with a specialized APN in oncology | ||
| 520 | |a RESULTS: All APN interventions were recorded, representing 1240 phone calls and 162 consultations for 42 MM patients. Eighty-two calls were referred to the physician with 45 consultations triggered. Most of the calls were frequent within the few first months, with a high request for information and reassurance, especially for treatment-naive or relapsed patients. In our study, the APN was able to manage multiple side effects through care organization (i.e., hospitalizations, transfusions) and a careful coordination between the primary care team and the hospital | ||
| 520 | |a DISCUSSION: In order to respond to the high need for care pathway and safety improvement, especially in elderly population, we have initiated an original follow-up by an APN for MM patients treated with oral chemotherapy. While the role of APN has become prominent in the oncology field in recent years, its holistic approach has to be emphasized in further studies to bring a comprehensive perspective to health care coordination in the future | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Advanced practice nurse | |
| 650 | 4 | |a Multiple myeloma | |
| 650 | 4 | |a Oral chemotherapy | |
| 650 | 4 | |a Remote follow-up | |
| 650 | 4 | |a Safety monitoring | |
| 650 | 4 | |a Side-effect management | |
| 700 | 1 | |a Migala, Cécile |e verfasserin |4 aut | |
| 700 | 1 | |a Daguenet, Elisabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Collet, Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Boussoualim, Karima |e verfasserin |4 aut | |
| 700 | 1 | |a Thomas, Thierry |e verfasserin |4 aut | |
| 700 | 1 | |a Guyotat, Denis |e verfasserin |4 aut | |
| 700 | 1 | |a Augeul-Meunier, Karine |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bulletin du cancer |d 1966 |g 110(2023), 12 vom: 01. Dez., Seite 1251-1259 |w (DE-627)NLM000155853 |x 1769-6917 |7 nnns |
| 773 | 1 | 8 | |g volume:110 |g year:2023 |g number:12 |g day:01 |g month:12 |g pages:1251-1259 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.bulcan.2023.07.010 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 110 |j 2023 |e 12 |b 01 |c 12 |h 1251-1259 | ||